Every one of those 1 sits in a single category, medical-devices. Of the tracked stories, 1 of 1 also mention AI-based breast cancer detection device, the most common co-covered peer. C-MET appears in 1 tracked Healthcare story from March 11, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about C-MET
Every one of those 1 sits in a single category, medical-devices. Of the tracked stories, 1 of 1 also mention AI-based breast cancer detection device, the most common co-covered peer. C-MET appears in 1 tracked Healthcare story from March 11, 2026. The tracked stories average 2 original sources each.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 8 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering C-MET. Shared-story counts are live from our verified record — not editorial picks.
Lords Mark Industries has entered a strategic partnership with the Center for Materials for Electronics Technology (C-MET) to develop a pioneering AI-based breast cancer detection device. This collaboration aims to leverage advanced materials and artificial intelligence to create a non-invasive, highly accurate screening tool for early-stage diagnosis.